BDBM720921 (1'S,4'S)-6'-bromo-8-(difluoromethoxy)-3',3',5'-trifluoro-6-(trifluoromethyl)-3',4'-dihydro-2'H,3H-spiro[imidazo[1,2-a]pyridine-2,1'-naphthalen]-4'-ol and (1'S,4'R)-6'-bromo-8-(difluoromethoxy)-3',3',5'-trifluoro-6-(trifluoromethyl)-3',4'-dihydro-2'H,3H-spiro[imidazo[1,2-a]pyridine-2,1'-naphthalen]-4'-ol::US12226405, Example 18

SMILES O[C@@H]1c2c(ccc(Br)c2F)[C@]2(CN3C=C(C(F)(F)F)C=C(OC(F)F)C3=N2)CC1(F)F

InChI Key InChIKey=GZBRKGJJPKRVQS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 720921   

TargetEndothelial PAS domain-containing protein 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 720921BDBM720921((1'S,4'S)-6'-bromo-8-(difluoromethoxy)-3',3',5'-tr...)
Affinity DataIC50: 6nMAssay Description:The scintillation proximal assay (SPA) was based on a competition binding assay with the radio-ligand N-(3-chloro-5-fluorophenyl-4-t)-4-nitrobenzo[c]...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent